Medicaid Cuts, FDA Drug Decisions

Kilder

• STAT: Hospitals pursue deals to ensure survival as Trump’s Medicaid cuts loom
• Kff: Mapping the Global Health Landscape: Analysis of Fourteen International Organizations
• STAT: STAT+: FDA approves AstraZeneca breast cancer drug
• Raps: Recon: FDA approves AZ’s breast cancer drug over negative adcomm vote; Novartis sees setbacks for drugs targeting cholesterol, myotonic dystrophy - RAPS
• STAT: An administrative gap delays access to new pancreatic cancer treatment
• STAT: A breakthrough pancreatic cancer drug won approval. They still struggle to access it
• STAT: STAT+: Health care features prominently in Democrats’ agenda
• STAT: STAT+: Roivant lung disease drug hits mid-stage study goals
• Finance: These 2 Biotech Stocks Hit Record Highs Today – What’s Driving The Rallies? - Yahoo Finance
• STAT: FDA approves AstraZeneca breast cancer drug - STAT

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.